Crosspoint Capital Strategies’s Lam Research LRCX Stock Holding History

Crosspoint Capital Strategies’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-218,480	Closed	-$3.09M	–	145
2017 Q2	$3.09M	Buy	+218,480	New	+$3.2M	2.7%	27
2016 Q1	–	Sell	-29,490	Closed	-$234K	–	519
2015 Q4	$234K	Sell	29,490 -2,120	-7%	-$15.9K	0.06%	206
2015 Q3	$207K	Sell	31,610 -5,000	-14%	-$36.6K	0.24%	102
2015 Q2	$298K	Buy	36,610 +15,610	+74%	+$123K	0.08%	128
2015 Q1	$147K	Buy	+21,000	New	+$166K	0.07%	157
2014 Q2	–	Sell	-21,700	Closed	-$119K	–	584
2014 Q1	$119K	Hold	21,700	–	–	0.05%	166
2013 Q4	$111K	Buy	+21,700	New	+$114K	0.04%	179

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Crosspoint Capital Strategies's LRCX Position: Q3 2017 in Review

Crosspoint Capital Strategies sold out of Lam Research (LRCX) in Q3 2017, closing a stake of 218,480 shares — an estimated $3.09M sold.

Crosspoint Capital Strategies first reported a position in LRCX in Q4 2013 and held it in 7 quarters. The position peaked at $3.09M in Q2 2017. 755 funds tracked by Wall St. Rank hold LRCX as of Q3 2017.

Crosspoint Capital Strategies reported no remaining Lam Research position as of Q3 2017 after selling out during the quarter.
Crosspoint Capital Strategies sold 218,480 Lam Research shares in Q3 2017, an estimated $3.09M.
Crosspoint Capital Strategies first reported a position in Lam Research in Q4 2013 and held it in 7 quarters.
Crosspoint Capital Strategies's Lam Research position peaked at $3.09M in Q2 2017.
755 funds tracked by Wall St. Rank held Lam Research as of Q3 2017.

Based on Crosspoint Capital Strategies's 13F filing for Q3 2017, filed 6 Nov 2017.